ORIC earnings date and last-quarter result: next report 2026-08-11, last quarter miss, P/E -7.47. Updated 2026-07-23.
ORIC Pharmaceuticals (ORIC) Research Hub
ORIC Pharmaceuticals (ORIC) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 8.96 USD (-31.97%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -7.47, market cap 1.09B. This hub links to the full technical, earnings and options research available for ORIC.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 8.96 USD (-31.97%) |
| 52-week range | 8.13 USD – 14.68 USD |
| Trend regime | Range |
| 14-day RSI | 33.3 (Bearish) |
| Trailing P/E | -7.47 |
| Market cap | 1.09B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for ORIC
Covered Call on ORIC: how it works, illustrative setup around the real 8.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ORIC: how it works, illustrative setup around the real 8.96 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ORIC: how it works, illustrative setup around the real 8.96 USD price, max profit/loss, breakeven and when to use it. Educational.
ORIC technical analysis: range, last 8.96 USD, RSI 33.3, 52w range 8.13 USD–14.68 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ORIC in?
ORIC Pharmaceuticals (ORIC) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is ORIC in an uptrend or downtrend?
As of 2026-10-26, ORIC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ORIC's trailing P/E ratio?
ORIC's trailing P/E is -7.47, with a market cap of 1.09B. See the earnings research page for full valuation detail.
When does ORIC next report earnings?
ORIC is next scheduled to report earnings on 2026-08-11.